Developing IVF solutions based on rigorous scientific evidence
We are a team of reproductive scientists and medical doctors with more than two decades of experience in the fertility space.
Our work that uncovered why egg quality in mammals is suboptimal has been published in top scientific journals such as Nature, Science and Cell.
Now, we are on a mission to translate these therapeutics to the clinic to shift the boundaries of IVF and transform lives through innovative fertility solutions.
The science behind our technology
We were the first team to visualise how human eggs retrieved for IVF purposes develop and eliminate half of their DNA to prepare for fertilisation. This allowed us to understand why this process goes wrong in so many women. Moreover, why its fidelity declines specifically with maternal age. These mechanisms explain the vast majority of errors seen in ageing human eggs.
Based on two decades of rigorous and groundbreaking research, Ovo Labs is developing a series of therapeutics that act on different molecular mechanisms related to egg cell division. These therapeutics have the potential to increase IVF success rates by 20-30% for women below 35 and by 3-5 times for women aged 35-45, having a potential for the biggest improvement in the infertility treatment since the introduction of IVF in 1978.
